Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes

AIMS/HYPOTHESIS: Individuals with heterozygous activating mutations of the KCNJ11 gene encoding a subunit of the ATP-sensitive potassium channel (KATP) can usually be treated with oral sulfonylurea (SU) pills in lieu of insulin injections. The aim of this study was to test our hypothesis that younge...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetologia
Main Authors: Thurber, Brian W., Carmody, David, Tadie, Elizabeth C., Pastore, Ashley N., Dickens, Jazzmyne T., Wroblewski, Kristen E., Naylor, Rochelle N., Philipson, Louis H., Greeley, Siri Atma W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4641523/
https://ncbi.nlm.nih.gov/pubmed/25877689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-015-3593-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados